Cargando…
Favorable Outcomes of Anticoagulation With Unfractioned Heparin in Sepsis-Induced Coagulopathy: A Retrospective Analysis of MIMIC-III Database
Backgrounds: Anticoagulation in sepsis-associated disseminated intravascular coagulation (DIC) remains uncertain. The aim of this study was to investigate whether unfractioned heparin (UFH) could improve clinical outcomes in patients with sepsis-induced coagulopathy (SIC). Methods: Septic patients w...
Autores principales: | Peng, Jiang-Chen, Nie, Fang, Li, Yu-Jie, Xu, Qiao-Yi, Xing, Shun-Peng, Li, Wen, Gao, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761617/ https://www.ncbi.nlm.nih.gov/pubmed/35047524 http://dx.doi.org/10.3389/fmed.2021.773339 |
Ejemplares similares
-
Development of a Nomogram to Predict 28-Day Mortality of Patients With Sepsis-Induced Coagulopathy: An Analysis of the MIMIC-III Database
por: Lu, Zongqing, et al.
Publicado: (2021) -
A randomized clinical trial of unfractioned heparin for treatment of sepsis (the HETRASE study): design and rationale [NCT00100308]
por: Jaimes, Fabián, et al.
Publicado: (2006) -
Low molecular weight heparin versus unfractioned heparin for anticoagulation during perioperative extracorporeal membrane oxygenation: A single center experience in 102 lung transplant patients
por: Gratz, Johannes, et al.
Publicado: (2020) -
Early prophylactic anticoagulation with heparin alleviates mortality in critically ill patients with sepsis: a retrospective analysis from the MIMIC-IV database
por: Zou, Zhi-ye, et al.
Publicado: (2022) -
Low-molecular-weight heparin therapy reduces 28-day mortality in patients with sepsis-3 by improving inflammation and coagulopathy
por: Zhang, Ze, et al.
Publicado: (2023)